Skip to main content
  1. Home
  2. Emerging Tech
  3. Health & Fitness
  4. News

The world’s first 3D printed, FDA-approved drug hits the market today

Add as a preferred source on Google

Since it seems like we’re 3D printing everything these days, it’s no surprise that one of the newest fields to jump on the bandwagon is the pharmaceutical industry. So far, a company called Aprecia Pharamceuticals has produced the only 3D printed drug to be approved by the FDA. This week, Aprecia is also becoming the first company to make their 3D printed drug, Spritam, available to the consumers in the United States.

There are certainly other pharmaceutical solutions coming out of 3D printers in labs, but they’re all still in the research phase. Spritam, on the other hand, has just become available to patients in the US who suffer from seizures. Aprecia uses a 3D process called powderbed inkjet printing that makes it possible to print ingestible tablets that dissolve immediately. Taking pills can be difficult and even dangerous for some patients, including the elderly. Spritam tablets deliver large amounts of the seizure medication in each dose, and their instantly dissoluble quality makes it easy for patients to take (when prescribed by a doctor).

Aprecia ZipDose Product Demonstration

Aprecia led a $35 million funding round to bring a series of alternative treatment solutions to patients suffering from conditions like epilepsy and myoclonic or tonic-clonic seizures. “Spritam is designed to transform what it is like to take epilepsy medication, and is the first in a line of products we are developing to provide patients and their caregivers with additional treatment options,” said Don Wetherhold, CEO of Apercia. If all the news is indeed connected behind Apercia’s laboratory doors, we may see many more 3D printed ingestible medications in the future.

Recommended Videos

3D printed medical solutions have been gaining lots of attention, but progress has been mainly in the category of hardware. And medication tablets coming off a 3D printer solves more than just the important component of instant dissolution — being able to print batches of FDA approved medications could mean that instead of having to adapt to pre-approved and mass produced dosage tablets, each patient could receive an individualized dosage or even a custom combination of drugs.

Chloe Olewitz
Former Digital Trends Contributor
Chloe is a writer from New York with a passion for technology, travel, and playing devil's advocate. You can find out more…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more